Subscribers to the ZYX Short Sell Change Alert took profits on Xenoport (XNPT) on May 5,2011 at $7.35. Following was the entry on the Real Time Feed: Most of our subscribers have already realized over 20% profit on XNPT over a very short time. After earnings report, the stock
The drug from Xenoport (XNPT) is for moderate to severe Restless Leg Syndrome. This drug will compete with existing treatments IT is not clear if the drug presents an advantage compared to the existing treatments with the exception of a small number of patients. It does not appear that the
Investors bid up shares of Xenoport (XNPT) by 56% on approval of Horizant.The company will have difficulty generating profits to support this huge stock move. We are now short from $10.18. For more details of the rationale to short sell, target tzone, stop zone,and real time updates, check out ZYX SHORT SELL CHANGE